EDSA
Closed
Edesa Biotech Inc
2.03
0.00 (0.00%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 2.03
Day's Range: 1.9923 - 2.07
Send
sign up or login to leave a comment!
When Written:
0.9121
Edesa Biotech Inc. is a clinical-stage biopharmaceutical company that develops novel treatments for inflammatory and immune-related diseases. The company is headquartered in Markham, Ontario, Canada, and was founded in 2015. Edesa's pipeline includes multiple drug candidates that target different diseases, including dermatitis, psoriasis, and COVID-19. The company's lead drug candidate, EB01, is a topical treatment for chronic allergic contact dermatitis and has completed a Phase 2b clinical trial. Edesa is also developing a monoclonal antibody treatment for COVID-19, currently in Phase 2 clinical trials. The company's mission is to improve patients' lives by developing innovative therapies that address unmet medical needs.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








